BREAKING NEWS

BREAKING NEWS

Roche posts modest third quarter sales beat as new drugs offset biosimilar hit

Now Reading :

Roche posts modest third quarter sales beat as new drugs offset biosimilar hit

Roche posts modest third quarter sales beat as new drugs offset biosimilar hit
@ Copyright :
ARND WIEGMANN(Reuters)
Text size Aa Aa

ZURICH (Reuters) - Roche's <ROG.S> third-quarter sales rose 7 percent, above analyst forecasts, as sales of new drugs including its multiple sclerosis therapy Ocrevus helped offset the impact that rivals' copies are having on the Swiss group's top-selling drugs.

Third-quarter sales rose to nearly 14 billion Swiss francs (£10.7 billion), compared to the average forecast of analysts of 13.8 billion francs in a Reuters poll.

Roche confirmed on Wednesday its outlook for 2018 sales to grow at a mid-single-digit rate. Core earnings per share, including benefits from U.S. tax reform changes, would grow in the mid-teen-digit percentages.

(Reporting by John Miller; Editing by Michael Shields)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.